APASL COVID-19 Hepatology Task Force has published clinical practice guidance!
You can read and download the guidance from This PAGE.
May 15, 2020
“We need hope but not false hope” NEVER in the history of mankind should we be more united to confront a common deadly enemy-Covid-19. To win this war for human race, we need knowledge from at all fronts, be united for critical thinking and there should be no room for finger-pointing. Without immunity and any highly effective treatment, we can only anticipate more casualties directly or indirectly from COVID-19. So far, tremendous effort has been exercised to control new human transmission by social isolation and quarantine. However, this can only “flatten but not to eliminate the curve”. The cost of these measures is also tremendous making life. especially in the lower social sector, intolerable. We need to figure out a better solution to prevent and to treat COVID-19, as it is unlikely to go away shortly. On the other hand, we also need to have people back to work or to schooling safely. To this end, we have organized a series of webinar with experts in various field to enlightened us the most recent Asia-Pacific data in epidemiology, diagnostic test, treatment and measures to control infection transmission and fatality rate.
We look forward to your participation!
Yours sincerely Masao Omata MD / George Lau MD Conveners of APASL COVID-19 Taskforce
New articles on COVID-19
4 new articles on COVID-19 and the liver have been recently published onlinein Hepatology International.
On behalf of Thai Association for Study of the Liver, it is our great pleasure to invite you to participate in the 30th Asian Pacific for The Study of Liver (APASL) in Bangkok, Thailand.
Since 1978, APASL has been actively striving towards the advancements of Hepatology studies. Our main objectives are to promote the latest scientific advancement and education of hepatology science, exchange of information and the development of consensus, encourage the practice of medicine in liver diseases and also coordinate scientific studies between various scientists and clinicians throughout the region.
APASL Bangkok will continue to reinforce these objectives, bringing together experts and veterans in the hepatology field from all around Asia Pacific, as well as in the world. The congress will feature a finely cultivated scientific programme, delivered by the best speakers, together with many interactive sessions and social programmes, promising the best platform for our participants to exchange knowledge and growth. Additionally, abstract competition and workshops will enhance the learning experience. APASL Bangkok will also be an excellent platform for industry players and trade companies to showcase the latest products and solutions.
The congress will be held in Bangkok, Thailand - the leading metropolitan area in Asia. You will enjoy a unique and inspiring experience with Thailand's distinctive culture and legendary hospitality.
We look forward to seeing you in Bangkok!"
- Dr Tawesak Tanwandee, APASL President (with effect from March 2020)
Invitation for application of APASL Awards
Named Award and Rising Star Award will be included in the scientific program of APASL Annual Meetings.
Named Awards "APASL Okuda-Omata Distinguished Award" "APASL Powell-Sarin Achievement Award" "APASL Lesmana-Sollano Great Mentor Award"
APASL will offer USD 5,000 for each.
<Selection Criteria for Named Awards> High original scientific research and achievements in a given area of liver diseases Continuous contribution to APASL activities and leadership role in academics and science in the field of Hepatology Persons with at least ten papers in Hepatology International, including five papers with his/her name as the first or as the correspondence author will be considered
Rising Star Award (Five Presenters)
APASL will offer USD 2,000 for each.
<Selection Criteria for Rising Star Award> Active scientific research in the field of Hepatology in process Willingness to contribute APASL activities Continuous attendance to APASL activities Age younger than 40 years Persons with at least five papers in Hepatology International , including three papers with his/her name as the first or as the correspondence author will be considered
Submission Deadline: 7, December 2020
Further details will be announced soon.
APASL STC on Elimination of Hepatitis C in Myanmar
APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)
*This APASL Guideline can be downloaded by clicking below.
The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2020-2021 fellowship.
An application form can be downloaded by clicking here: Click here! Please fill in and send to the APASL secretariat (firstname.lastname@example.org). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.